DERM
Journey Medical Corporation
Drug Manufacturers - Specialty & Generic · Healthcare · United States
5.17
close · 2026-10-30
value
11
cheaper than peers11
quality
36
stronger fundamentals36
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 2.26× | 55 |
| earnings yield, 2 years ago | -4.1% | 44 |
| cash flow yield, 2 years ago | 0.2% | 43 |
| price to book | 4.45× | 33 |
| earnings yield, latest year | -9.1% | 23 |
| earnings yield, 1 year ago | -13.9% | 21 |
| cash flow yield, latest year | -8.5% | 18 |
| cash flow yield, 3 years ago | -23.0% | 16 |
| earnings yield, 3 years ago | -32.7% | 14 |
| cash flow yield, 1 year ago | -16.5% | 9 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 21.5% | 80 |
| debt to equity | 82.6% | 47 |
| operating margin | -9.3% | 26 |
| return on equity | -36.6% | 22 |
4 of 4 measures available
Facts
| market cap | $146M |
| free cash flow | -$3.3M |
| employees | 58 |
| first trade | 2021-11-12 |
| next earnings | 2026-08-12 |
| fundamentals updated | 2026-08-12 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.47 | -0.72 | -0.21 | -1.69 |
| free cash flow | -$12.4M | -$24.1M | $240,000 | -$33.5M |
| net income | -$11.4M | -$14.7M | -$3.9M | -$29.6M |
| revenue | $61.9M | $56.1M | $79.2M | $73.7M |
| unusual items | -$90,000 | $5.6M | -$3.3M | -$89,000 |